ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Pain Management Drug Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-0T15701
Home | Market Reports | Health| Health Conditions| Pain Management
Global Human Pain Management Drug Market Research Report 2023
BUY CHAPTERS

Global Human Pain Management Drug Market Research Report 2025

Code: QYRE-Auto-0T15701
Report
May 2025
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbvie inc. (Allergan Plc)
Bristol-Myers Squibb Co
Sanofi
Boehringer Ingelheim International GmbH
Pfizer Inc
Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
GSK
Abbott Laboratories Inc
Novartis
Johnson& Johnson (Janssen Pharmaceuticals Inc.)
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals Inc
Bayer
F Hoffmann La Roche Ltd
Procter Gamble
Astrazeneca plc
Cardinal Health
Perrigo Company plc
Bausch Health Companies Inc.
Viatris
Amneal Pharmaceuticals
Purdue Pharmaceuticals L.P.

Human Pain Management Drug Market Size

The global market for Human Pain Management Drug was valued at US$ 77860 million in the year 2024 and is projected to reach a revised size of US$ 103430 million by 2031, growing at a CAGR of 4.2% during the forecast period.

Human Pain Management Drug Market

Human Pain Management Drug Market

Pain relievers, including acetaminophen, NSAIDs and opioids, can ease temporary aches and chronic pain.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Human Pain Management Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Pain Management Drug.
The Human Pain Management Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Pain Management Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Pain Management Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Human Pain Management Drug Market Report

Report Metric Details
Report Name Human Pain Management Drug Market
Accounted market size in year US$ 77860 million
Forecasted market size in 2031 US$ 103430 million
CAGR 4.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • OTC
  • Rx
Segment by Application
  • Hospital
  • Retail Pharmacy
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie Inc. (Allergan plc), Bristol Myers Squibb Co., Sanofi S.A., Boehringer Ingelheim International GmbH, Pfizer Inc., Zydus Lifesciences Ltd. (Cadila Pharmaceuticals), GSK plc., Abbott Laboratories, Inc., Novartis AG, Johnson & Johnson (Janssen Pharmaceuticals, Inc.), Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals Ltd., Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Procter & Gamble, AstraZeneca, Cardinal Health, Perrigo Company Plc., Bausch Health Companies Inc., Viatris, Amneal Pharmaceuticals, Purdue Pharmaceuticals L.P.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Human Pain Management Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Human Pain Management Drug Market growing?

Ans: The Human Pain Management Drug Market witnessing a CAGR of 4.2% during the forecast period 2025-2031.

What is the Human Pain Management Drug Market size in 2031?

Ans: The Human Pain Management Drug Market size in 2031 will be US$ 103430 million.

Who are the main players in the Human Pain Management Drug Market report?

Ans: The main players in the Human Pain Management Drug Market are AbbVie Inc. (Allergan plc), Bristol Myers Squibb Co., Sanofi S.A., Boehringer Ingelheim International GmbH, Pfizer Inc., Zydus Lifesciences Ltd. (Cadila Pharmaceuticals), GSK plc., Abbott Laboratories, Inc., Novartis AG, Johnson & Johnson (Janssen Pharmaceuticals, Inc.), Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals Ltd., Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Procter & Gamble, AstraZeneca, Cardinal Health, Perrigo Company Plc., Bausch Health Companies Inc., Viatris, Amneal Pharmaceuticals, Purdue Pharmaceuticals L.P.

What are the Application segmentation covered in the Human Pain Management Drug Market report?

Ans: The Applications covered in the Human Pain Management Drug Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Human Pain Management Drug Market report?

Ans: The Types covered in the Human Pain Management Drug Market report are OTC, Rx

Recommended Reports

Pain Management Drugs

Over-the-Counter Analgesics

Anti-Inflammatory Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Pain Management Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 OTC
1.2.3 Rx
1.3 Market by Application
1.3.1 Global Human Pain Management Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Pain Management Drug Market Perspective (2020-2031)
2.2 Global Human Pain Management Drug Growth Trends by Region
2.2.1 Global Human Pain Management Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Human Pain Management Drug Historic Market Size by Region (2020-2025)
2.2.3 Human Pain Management Drug Forecasted Market Size by Region (2026-2031)
2.3 Human Pain Management Drug Market Dynamics
2.3.1 Human Pain Management Drug Industry Trends
2.3.2 Human Pain Management Drug Market Drivers
2.3.3 Human Pain Management Drug Market Challenges
2.3.4 Human Pain Management Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Pain Management Drug Players by Revenue
3.1.1 Global Top Human Pain Management Drug Players by Revenue (2020-2025)
3.1.2 Global Human Pain Management Drug Revenue Market Share by Players (2020-2025)
3.2 Global Human Pain Management Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Human Pain Management Drug Revenue
3.4 Global Human Pain Management Drug Market Concentration Ratio
3.4.1 Global Human Pain Management Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Pain Management Drug Revenue in 2024
3.5 Global Key Players of Human Pain Management Drug Head office and Area Served
3.6 Global Key Players of Human Pain Management Drug, Product and Application
3.7 Global Key Players of Human Pain Management Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Pain Management Drug Breakdown Data by Type
4.1 Global Human Pain Management Drug Historic Market Size by Type (2020-2025)
4.2 Global Human Pain Management Drug Forecasted Market Size by Type (2026-2031)
5 Human Pain Management Drug Breakdown Data by Application
5.1 Global Human Pain Management Drug Historic Market Size by Application (2020-2025)
5.2 Global Human Pain Management Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Human Pain Management Drug Market Size (2020-2031)
6.2 North America Human Pain Management Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Human Pain Management Drug Market Size by Country (2020-2025)
6.4 North America Human Pain Management Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Pain Management Drug Market Size (2020-2031)
7.2 Europe Human Pain Management Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Human Pain Management Drug Market Size by Country (2020-2025)
7.4 Europe Human Pain Management Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Pain Management Drug Market Size (2020-2031)
8.2 Asia-Pacific Human Pain Management Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Human Pain Management Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Human Pain Management Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Pain Management Drug Market Size (2020-2031)
9.2 Latin America Human Pain Management Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Human Pain Management Drug Market Size by Country (2020-2025)
9.4 Latin America Human Pain Management Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Pain Management Drug Market Size (2020-2031)
10.2 Middle East & Africa Human Pain Management Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Human Pain Management Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Human Pain Management Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie Inc. (Allergan plc)
11.1.1 AbbVie Inc. (Allergan plc) Company Details
11.1.2 AbbVie Inc. (Allergan plc) Business Overview
11.1.3 AbbVie Inc. (Allergan plc) Human Pain Management Drug Introduction
11.1.4 AbbVie Inc. (Allergan plc) Revenue in Human Pain Management Drug Business (2020-2025)
11.1.5 AbbVie Inc. (Allergan plc) Recent Development
11.2 Bristol Myers Squibb Co.
11.2.1 Bristol Myers Squibb Co. Company Details
11.2.2 Bristol Myers Squibb Co. Business Overview
11.2.3 Bristol Myers Squibb Co. Human Pain Management Drug Introduction
11.2.4 Bristol Myers Squibb Co. Revenue in Human Pain Management Drug Business (2020-2025)
11.2.5 Bristol Myers Squibb Co. Recent Development
11.3 Sanofi S.A.
11.3.1 Sanofi S.A. Company Details
11.3.2 Sanofi S.A. Business Overview
11.3.3 Sanofi S.A. Human Pain Management Drug Introduction
11.3.4 Sanofi S.A. Revenue in Human Pain Management Drug Business (2020-2025)
11.3.5 Sanofi S.A. Recent Development
11.4 Boehringer Ingelheim International GmbH
11.4.1 Boehringer Ingelheim International GmbH Company Details
11.4.2 Boehringer Ingelheim International GmbH Business Overview
11.4.3 Boehringer Ingelheim International GmbH Human Pain Management Drug Introduction
11.4.4 Boehringer Ingelheim International GmbH Revenue in Human Pain Management Drug Business (2020-2025)
11.4.5 Boehringer Ingelheim International GmbH Recent Development
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Details
11.5.2 Pfizer Inc. Business Overview
11.5.3 Pfizer Inc. Human Pain Management Drug Introduction
11.5.4 Pfizer Inc. Revenue in Human Pain Management Drug Business (2020-2025)
11.5.5 Pfizer Inc. Recent Development
11.6 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
11.6.1 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Company Details
11.6.2 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Business Overview
11.6.3 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Introduction
11.6.4 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Revenue in Human Pain Management Drug Business (2020-2025)
11.6.5 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Recent Development
11.7 GSK plc.
11.7.1 GSK plc. Company Details
11.7.2 GSK plc. Business Overview
11.7.3 GSK plc. Human Pain Management Drug Introduction
11.7.4 GSK plc. Revenue in Human Pain Management Drug Business (2020-2025)
11.7.5 GSK plc. Recent Development
11.8 Abbott Laboratories, Inc.
11.8.1 Abbott Laboratories, Inc. Company Details
11.8.2 Abbott Laboratories, Inc. Business Overview
11.8.3 Abbott Laboratories, Inc. Human Pain Management Drug Introduction
11.8.4 Abbott Laboratories, Inc. Revenue in Human Pain Management Drug Business (2020-2025)
11.8.5 Abbott Laboratories, Inc. Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Details
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Human Pain Management Drug Introduction
11.9.4 Novartis AG Revenue in Human Pain Management Drug Business (2020-2025)
11.9.5 Novartis AG Recent Development
11.10 Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
11.10.1 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Details
11.10.2 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Business Overview
11.10.3 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Introduction
11.10.4 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Revenue in Human Pain Management Drug Business (2020-2025)
11.10.5 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Recent Development
11.11 Sun Pharmaceutical Industries Ltd.
11.11.1 Sun Pharmaceutical Industries Ltd. Company Details
11.11.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.11.3 Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Introduction
11.11.4 Sun Pharmaceutical Industries Ltd. Revenue in Human Pain Management Drug Business (2020-2025)
11.11.5 Sun Pharmaceutical Industries Ltd. Recent Development
11.12 Teva Pharmaceuticals Ltd.
11.12.1 Teva Pharmaceuticals Ltd. Company Details
11.12.2 Teva Pharmaceuticals Ltd. Business Overview
11.12.3 Teva Pharmaceuticals Ltd. Human Pain Management Drug Introduction
11.12.4 Teva Pharmaceuticals Ltd. Revenue in Human Pain Management Drug Business (2020-2025)
11.12.5 Teva Pharmaceuticals Ltd. Recent Development
11.13 Mallinckrodt Pharmaceuticals
11.13.1 Mallinckrodt Pharmaceuticals Company Details
11.13.2 Mallinckrodt Pharmaceuticals Business Overview
11.13.3 Mallinckrodt Pharmaceuticals Human Pain Management Drug Introduction
11.13.4 Mallinckrodt Pharmaceuticals Revenue in Human Pain Management Drug Business (2020-2025)
11.13.5 Mallinckrodt Pharmaceuticals Recent Development
11.14 Endo Pharmaceuticals Inc.
11.14.1 Endo Pharmaceuticals Inc. Company Details
11.14.2 Endo Pharmaceuticals Inc. Business Overview
11.14.3 Endo Pharmaceuticals Inc. Human Pain Management Drug Introduction
11.14.4 Endo Pharmaceuticals Inc. Revenue in Human Pain Management Drug Business (2020-2025)
11.14.5 Endo Pharmaceuticals Inc. Recent Development
11.15 Bayer AG
11.15.1 Bayer AG Company Details
11.15.2 Bayer AG Business Overview
11.15.3 Bayer AG Human Pain Management Drug Introduction
11.15.4 Bayer AG Revenue in Human Pain Management Drug Business (2020-2025)
11.15.5 Bayer AG Recent Development
11.16 F. Hoffmann-La Roche Ltd.
11.16.1 F. Hoffmann-La Roche Ltd. Company Details
11.16.2 F. Hoffmann-La Roche Ltd. Business Overview
11.16.3 F. Hoffmann-La Roche Ltd. Human Pain Management Drug Introduction
11.16.4 F. Hoffmann-La Roche Ltd. Revenue in Human Pain Management Drug Business (2020-2025)
11.16.5 F. Hoffmann-La Roche Ltd. Recent Development
11.17 Procter & Gamble
11.17.1 Procter & Gamble Company Details
11.17.2 Procter & Gamble Business Overview
11.17.3 Procter & Gamble Human Pain Management Drug Introduction
11.17.4 Procter & Gamble Revenue in Human Pain Management Drug Business (2020-2025)
11.17.5 Procter & Gamble Recent Development
11.18 AstraZeneca
11.18.1 AstraZeneca Company Details
11.18.2 AstraZeneca Business Overview
11.18.3 AstraZeneca Human Pain Management Drug Introduction
11.18.4 AstraZeneca Revenue in Human Pain Management Drug Business (2020-2025)
11.18.5 AstraZeneca Recent Development
11.19 Cardinal Health
11.19.1 Cardinal Health Company Details
11.19.2 Cardinal Health Business Overview
11.19.3 Cardinal Health Human Pain Management Drug Introduction
11.19.4 Cardinal Health Revenue in Human Pain Management Drug Business (2020-2025)
11.19.5 Cardinal Health Recent Development
11.20 Perrigo Company Plc.
11.20.1 Perrigo Company Plc. Company Details
11.20.2 Perrigo Company Plc. Business Overview
11.20.3 Perrigo Company Plc. Human Pain Management Drug Introduction
11.20.4 Perrigo Company Plc. Revenue in Human Pain Management Drug Business (2020-2025)
11.20.5 Perrigo Company Plc. Recent Development
11.21 Bausch Health Companies Inc.
11.21.1 Bausch Health Companies Inc. Company Details
11.21.2 Bausch Health Companies Inc. Business Overview
11.21.3 Bausch Health Companies Inc. Human Pain Management Drug Introduction
11.21.4 Bausch Health Companies Inc. Revenue in Human Pain Management Drug Business (2020-2025)
11.21.5 Bausch Health Companies Inc. Recent Development
11.22 Viatris
11.22.1 Viatris Company Details
11.22.2 Viatris Business Overview
11.22.3 Viatris Human Pain Management Drug Introduction
11.22.4 Viatris Revenue in Human Pain Management Drug Business (2020-2025)
11.22.5 Viatris Recent Development
11.23 Amneal Pharmaceuticals
11.23.1 Amneal Pharmaceuticals Company Details
11.23.2 Amneal Pharmaceuticals Business Overview
11.23.3 Amneal Pharmaceuticals Human Pain Management Drug Introduction
11.23.4 Amneal Pharmaceuticals Revenue in Human Pain Management Drug Business (2020-2025)
11.23.5 Amneal Pharmaceuticals Recent Development
11.24 Purdue Pharmaceuticals L.P.
11.24.1 Purdue Pharmaceuticals L.P. Company Details
11.24.2 Purdue Pharmaceuticals L.P. Business Overview
11.24.3 Purdue Pharmaceuticals L.P. Human Pain Management Drug Introduction
11.24.4 Purdue Pharmaceuticals L.P. Revenue in Human Pain Management Drug Business (2020-2025)
11.24.5 Purdue Pharmaceuticals L.P. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Abbvie inc. (Allergan Plc)
Bristol-Myers Squibb Co
Sanofi
Boehringer Ingelheim International GmbH
Pfizer Inc
Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
GSK
Abbott Laboratories Inc
Novartis
Johnson& Johnson (Janssen Pharmaceuticals Inc.)
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals Inc
Bayer
F Hoffmann La Roche Ltd
Procter Gamble
Astrazeneca plc
Cardinal Health
Perrigo Company plc
Bausch Health Companies Inc.
Viatris
Amneal Pharmaceuticals
Purdue Pharmaceuticals L.P.
List of Tables
 Table 1. Global Human Pain Management Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of OTC
 Table 3. Key Players of Rx
 Table 4. Global Human Pain Management Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Human Pain Management Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Human Pain Management Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Human Pain Management Drug Market Share by Region (2020-2025)
 Table 8. Global Human Pain Management Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Human Pain Management Drug Market Share by Region (2026-2031)
 Table 10. Human Pain Management Drug Market Trends
 Table 11. Human Pain Management Drug Market Drivers
 Table 12. Human Pain Management Drug Market Challenges
 Table 13. Human Pain Management Drug Market Restraints
 Table 14. Global Human Pain Management Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Human Pain Management Drug Market Share by Players (2020-2025)
 Table 16. Global Top Human Pain Management Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Pain Management Drug as of 2024)
 Table 17. Ranking of Global Top Human Pain Management Drug Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Human Pain Management Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Human Pain Management Drug, Headquarters and Area Served
 Table 20. Global Key Players of Human Pain Management Drug, Product and Application
 Table 21. Global Key Players of Human Pain Management Drug, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Human Pain Management Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Human Pain Management Drug Revenue Market Share by Type (2020-2025)
 Table 25. Global Human Pain Management Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Human Pain Management Drug Revenue Market Share by Type (2026-2031)
 Table 27. Global Human Pain Management Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Human Pain Management Drug Revenue Market Share by Application (2020-2025)
 Table 29. Global Human Pain Management Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Human Pain Management Drug Revenue Market Share by Application (2026-2031)
 Table 31. North America Human Pain Management Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Human Pain Management Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Human Pain Management Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Human Pain Management Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Human Pain Management Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Human Pain Management Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Human Pain Management Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Human Pain Management Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Human Pain Management Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Human Pain Management Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Human Pain Management Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Human Pain Management Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Human Pain Management Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Human Pain Management Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Human Pain Management Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 46. AbbVie Inc. (Allergan plc) Company Details
 Table 47. AbbVie Inc. (Allergan plc) Business Overview
 Table 48. AbbVie Inc. (Allergan plc) Human Pain Management Drug Product
 Table 49. AbbVie Inc. (Allergan plc) Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 50. AbbVie Inc. (Allergan plc) Recent Development
 Table 51. Bristol Myers Squibb Co. Company Details
 Table 52. Bristol Myers Squibb Co. Business Overview
 Table 53. Bristol Myers Squibb Co. Human Pain Management Drug Product
 Table 54. Bristol Myers Squibb Co. Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 55. Bristol Myers Squibb Co. Recent Development
 Table 56. Sanofi S.A. Company Details
 Table 57. Sanofi S.A. Business Overview
 Table 58. Sanofi S.A. Human Pain Management Drug Product
 Table 59. Sanofi S.A. Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 60. Sanofi S.A. Recent Development
 Table 61. Boehringer Ingelheim International GmbH Company Details
 Table 62. Boehringer Ingelheim International GmbH Business Overview
 Table 63. Boehringer Ingelheim International GmbH Human Pain Management Drug Product
 Table 64. Boehringer Ingelheim International GmbH Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 65. Boehringer Ingelheim International GmbH Recent Development
 Table 66. Pfizer Inc. Company Details
 Table 67. Pfizer Inc. Business Overview
 Table 68. Pfizer Inc. Human Pain Management Drug Product
 Table 69. Pfizer Inc. Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 70. Pfizer Inc. Recent Development
 Table 71. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Company Details
 Table 72. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Business Overview
 Table 73. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Product
 Table 74. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 75. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Recent Development
 Table 76. GSK plc. Company Details
 Table 77. GSK plc. Business Overview
 Table 78. GSK plc. Human Pain Management Drug Product
 Table 79. GSK plc. Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 80. GSK plc. Recent Development
 Table 81. Abbott Laboratories, Inc. Company Details
 Table 82. Abbott Laboratories, Inc. Business Overview
 Table 83. Abbott Laboratories, Inc. Human Pain Management Drug Product
 Table 84. Abbott Laboratories, Inc. Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 85. Abbott Laboratories, Inc. Recent Development
 Table 86. Novartis AG Company Details
 Table 87. Novartis AG Business Overview
 Table 88. Novartis AG Human Pain Management Drug Product
 Table 89. Novartis AG Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 90. Novartis AG Recent Development
 Table 91. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Details
 Table 92. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Business Overview
 Table 93. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Product
 Table 94. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 95. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Recent Development
 Table 96. Sun Pharmaceutical Industries Ltd. Company Details
 Table 97. Sun Pharmaceutical Industries Ltd. Business Overview
 Table 98. Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Product
 Table 99. Sun Pharmaceutical Industries Ltd. Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 100. Sun Pharmaceutical Industries Ltd. Recent Development
 Table 101. Teva Pharmaceuticals Ltd. Company Details
 Table 102. Teva Pharmaceuticals Ltd. Business Overview
 Table 103. Teva Pharmaceuticals Ltd. Human Pain Management Drug Product
 Table 104. Teva Pharmaceuticals Ltd. Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 105. Teva Pharmaceuticals Ltd. Recent Development
 Table 106. Mallinckrodt Pharmaceuticals Company Details
 Table 107. Mallinckrodt Pharmaceuticals Business Overview
 Table 108. Mallinckrodt Pharmaceuticals Human Pain Management Drug Product
 Table 109. Mallinckrodt Pharmaceuticals Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 110. Mallinckrodt Pharmaceuticals Recent Development
 Table 111. Endo Pharmaceuticals Inc. Company Details
 Table 112. Endo Pharmaceuticals Inc. Business Overview
 Table 113. Endo Pharmaceuticals Inc. Human Pain Management Drug Product
 Table 114. Endo Pharmaceuticals Inc. Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 115. Endo Pharmaceuticals Inc. Recent Development
 Table 116. Bayer AG Company Details
 Table 117. Bayer AG Business Overview
 Table 118. Bayer AG Human Pain Management Drug Product
 Table 119. Bayer AG Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 120. Bayer AG Recent Development
 Table 121. F. Hoffmann-La Roche Ltd. Company Details
 Table 122. F. Hoffmann-La Roche Ltd. Business Overview
 Table 123. F. Hoffmann-La Roche Ltd. Human Pain Management Drug Product
 Table 124. F. Hoffmann-La Roche Ltd. Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 125. F. Hoffmann-La Roche Ltd. Recent Development
 Table 126. Procter & Gamble Company Details
 Table 127. Procter & Gamble Business Overview
 Table 128. Procter & Gamble Human Pain Management Drug Product
 Table 129. Procter & Gamble Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 130. Procter & Gamble Recent Development
 Table 131. AstraZeneca Company Details
 Table 132. AstraZeneca Business Overview
 Table 133. AstraZeneca Human Pain Management Drug Product
 Table 134. AstraZeneca Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 135. AstraZeneca Recent Development
 Table 136. Cardinal Health Company Details
 Table 137. Cardinal Health Business Overview
 Table 138. Cardinal Health Human Pain Management Drug Product
 Table 139. Cardinal Health Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 140. Cardinal Health Recent Development
 Table 141. Perrigo Company Plc. Company Details
 Table 142. Perrigo Company Plc. Business Overview
 Table 143. Perrigo Company Plc. Human Pain Management Drug Product
 Table 144. Perrigo Company Plc. Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 145. Perrigo Company Plc. Recent Development
 Table 146. Bausch Health Companies Inc. Company Details
 Table 147. Bausch Health Companies Inc. Business Overview
 Table 148. Bausch Health Companies Inc. Human Pain Management Drug Product
 Table 149. Bausch Health Companies Inc. Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 150. Bausch Health Companies Inc. Recent Development
 Table 151. Viatris Company Details
 Table 152. Viatris Business Overview
 Table 153. Viatris Human Pain Management Drug Product
 Table 154. Viatris Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 155. Viatris Recent Development
 Table 156. Amneal Pharmaceuticals Company Details
 Table 157. Amneal Pharmaceuticals Business Overview
 Table 158. Amneal Pharmaceuticals Human Pain Management Drug Product
 Table 159. Amneal Pharmaceuticals Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 160. Amneal Pharmaceuticals Recent Development
 Table 161. Purdue Pharmaceuticals L.P. Company Details
 Table 162. Purdue Pharmaceuticals L.P. Business Overview
 Table 163. Purdue Pharmaceuticals L.P. Human Pain Management Drug Product
 Table 164. Purdue Pharmaceuticals L.P. Revenue in Human Pain Management Drug Business (2020-2025) & (US$ Million)
 Table 165. Purdue Pharmaceuticals L.P. Recent Development
 Table 166. Research Programs/Design for This Report
 Table 167. Key Data Information from Secondary Sources
 Table 168. Key Data Information from Primary Sources
 Table 169. Authors List of This Report


List of Figures
 Figure 1. Human Pain Management Drug Picture
 Figure 2. Global Human Pain Management Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Human Pain Management Drug Market Share by Type: 2024 VS 2031
 Figure 4. OTC Features
 Figure 5. Rx Features
 Figure 6. Global Human Pain Management Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Human Pain Management Drug Market Share by Application: 2024 VS 2031
 Figure 8. Hospital Case Studies
 Figure 9. Retail Pharmacy Case Studies
 Figure 10. Other Case Studies
 Figure 11. Human Pain Management Drug Report Years Considered
 Figure 12. Global Human Pain Management Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Human Pain Management Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Human Pain Management Drug Market Share by Region: 2024 VS 2031
 Figure 15. Global Human Pain Management Drug Market Share by Players in 2024
 Figure 16. Global Top Human Pain Management Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Pain Management Drug as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Human Pain Management Drug Revenue in 2024
 Figure 18. North America Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Human Pain Management Drug Market Share by Country (2020-2031)
 Figure 20. United States Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Human Pain Management Drug Market Share by Country (2020-2031)
 Figure 24. Germany Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Human Pain Management Drug Market Share by Region (2020-2031)
 Figure 32. China Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Human Pain Management Drug Market Share by Country (2020-2031)
 Figure 40. Mexico Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Human Pain Management Drug Market Share by Country (2020-2031)
 Figure 44. Turkey Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Human Pain Management Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. AbbVie Inc. (Allergan plc) Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 48. Bristol Myers Squibb Co. Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 49. Sanofi S.A. Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 50. Boehringer Ingelheim International GmbH Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 51. Pfizer Inc. Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 52. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 53. GSK plc. Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 54. Abbott Laboratories, Inc. Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 55. Novartis AG Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 56. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 57. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 58. Teva Pharmaceuticals Ltd. Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 59. Mallinckrodt Pharmaceuticals Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 60. Endo Pharmaceuticals Inc. Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 61. Bayer AG Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 62. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 63. Procter & Gamble Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 64. AstraZeneca Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 65. Cardinal Health Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 66. Perrigo Company Plc. Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 67. Bausch Health Companies Inc. Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 68. Viatris Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 69. Amneal Pharmaceuticals Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 70. Purdue Pharmaceuticals L.P. Revenue Growth Rate in Human Pain Management Drug Business (2020-2025)
 Figure 71. Bottom-up and Top-down Approaches for This Report
 Figure 72. Data Triangulation
 Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Painkiller Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
OTC Painkiller Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pain Management Product Market
Osteoarthritis Pain Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pain Care Products Market Research Report 2024
Global Drugs for Pain Management Market Insights Forecast to 2030
Osteoarthritis Medications Market
Global Pain Management Drugs Market Research Report 2025
Global OTC Pain Medications Market Research Report 2024
Global Over the Counter Pain Medication Market Research Report 2024
Global Lower Back Pain Drug Market Research Report 2025
Analgesic and Anti inflammatory API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pain Relievers for Teeth Market Research Report 2025
Injectable Pain Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prescription Pain Medications Market Research Report 2025
Medications for Chronic Pain Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pain Control Therapy Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Pain Topical Analgesics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Osteoarthritis Pain Drugs Market Insights Forecast to 2030
Osteoarthritis Drugs Market
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions